AAAAAA

   
Results: 1-12 |
Results: 12
Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856
Authors: Lester, EP Petroni, GR Barcos, M Johnson, JL Millard, FE Cooper, MR Omura, GA Frei, E Peterson, BA
Citation: Ep. Lester et al., Cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) for advanced-stage Hodgkin's disease: CALGB 8856, CANCER INV, 19(5), 2001, pp. 447-458
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma
Authors: Duvic, M Olsen, EA Omura, GA Maize, JC Vonderheid, EC Elmets, CA Shupack, JL Demierre, MF Kuzel, TM Sanders, DY
Citation: M. Duvic et al., A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma, J AM ACAD D, 44(6), 2001, pp. 940-947
Oncologic interventions: What is the goal?
Authors: Omura, GA
Citation: Ga. Omura, Oncologic interventions: What is the goal?, GYNECOL ONC, 80(2), 2001, pp. 331-331
Cytoreductive surgery for ovarian cancer
Authors: Omura, GA
Citation: Ga. Omura, Cytoreductive surgery for ovarian cancer, GYNECOL ONC, 80(2), 2001, pp. 332-332
Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, andetoposide (CHOPE) chemotherapy for patients with diffuse lymphoma - Cancerand Leukemia Group B Studies 8852 and 8854
Authors: Bartlett, NL Petroni, GR Parker, BA Wagner, ND Gockerman, JP Omura, GA Canellos, GP Cooper, MR Johnson, JL Peterson, BA
Citation: Nl. Bartlett et al., Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, andetoposide (CHOPE) chemotherapy for patients with diffuse lymphoma - Cancerand Leukemia Group B Studies 8852 and 8854, CANCER, 92(2), 2001, pp. 207-217
Arsenic therapy
Authors: Omura, GA
Citation: Ga. Omura, Arsenic therapy, ARCH DERMAT, 137(6), 2001, pp. 823-824
Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis
Authors: Morris, PE Omura, GA
Citation: Pe. Morris et Ga. Omura, Inhibitors of the enzyme purine nucleoside phosphorylase as potential therapy for psoriasis, CUR PHARM D, 6(9), 2000, pp. 943-959
Chemotherapy of gestational trophoblastic disease
Authors: Omura, GA
Citation: Ga. Omura, Chemotherapy of gestational trophoblastic disease, J CL ONCOL, 18(10), 2000, pp. 2187-2187
In pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral dosesin healthy volunteers (vol 40, pg 410, 2000)
Authors: Viegas, TX Omura, GA Stoltz, RR Kisicki, JT
Citation: Tx. Viegas et al., In pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral dosesin healthy volunteers (vol 40, pg 410, 2000), J CLIN PHAR, 40(6), 2000, pp. 664-664
Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses inhealthy volunteers
Authors: Viegas, TX Omura, GA Stoltz, RR Kisicki, J
Citation: Tx. Viegas et al., Pharmacokinetics and pharmacodynamics of peldesine (BCX-34), a purine nucleoside phosphorylase inhibitor, following single and multiple oral doses inhealthy volunteers, J CLIN PHAR, 40(4), 2000, pp. 410-420
Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials
Authors: Pasquali, S Maqueo, JD Vela, J Kyle, RA Leong, T Fritz, E Suciu, S Palva, IP Oivanen, T Corrado, C Lastiri, FJ Peest, D Kildahl-Andersen, O Maniatis, A Alison, R Clarke, M Evans, V Gray, R Greaves, E Hall, E Hicks, C James, S Peto, R Richards, S Sinclair, D Tooth, A Wheatley, K Avvisati, G Boccadoro, M Bugliosi, R Mandelli, F Petrucci, MT Pileri, A Tribalto, M Alexanian, R Delasalle, KB Child, J Dunn, J MacLennan, I Milligan, D Mellstedt, H Osterborg, A Hjorth, M Holmberg, E Rodjer, S Westin, J Kamiya, O Shimizu, K Bergsagel, DE Shustik, C Hippe, E Kjaersgaard, E Turesson, I Westin, J Riccardi, A Ucci, G Blade, J Fontanillas, M De Rosa, L Montuoro, A Bartolucci, AA Omura, GA Stagg, M Salmon, S Tangen, C Jacobs, P Wood, L Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842
A phase I study of paclitaxel, doxorubicin, and cisplatin in patients withpreviously untreated epithelial ovarian cancer
Authors: Naumann, RW Alvarez, RD Omura, GA Segars, E Kilgore, LC Partridge, EE
Citation: Rw. Naumann et al., A phase I study of paclitaxel, doxorubicin, and cisplatin in patients withpreviously untreated epithelial ovarian cancer, GYNECOL ONC, 71(3), 1998, pp. 450-453
Risultati: 1-12 |